P7977-2025 An Open-Label Study to Explore the Clinical Efficacy of PSI-7977 with Ribavirin Administered Pre- Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
Investigator: Eugene Schiff
Institutional Protocol #: 20111164
National Clinical Trials Identifier: N/A
Division: Cancer Center
Therapeutic Area: Pancreatic, Liver, and Related Cancers
Phase: Phase II/III
Enrolling Since: 5/16/2012